Symptoms fluctuate
A consultation captures only a fraction of what someone experiences over time.
Longitudinal neurological health
Neurological care sees minutes.
We capture the months between.
Mylenium is building longitudinal treatment-response infrastructure for neurological care.
For patients care teams research life sciences
The missing interval
What happens between appointments changes everything.
01Appointment
The missing information sits between appointments.
02Appointment
Treatment happens in the real world
Response changes alongside medication, function, sleep, stress, activity and daily life.
Clinical decisions still rely on snapshots
Important patterns can disappear between visits.
The architecture
One longitudinal intelligence layer.
The patient-facing layer generates the longitudinal data. Mylenium structures it for wider use.
01
Capture
Patient-generated information across movement, symptoms, treatment, function and context.
02
Understand
Build structured histories of change. Connect observations across days, weeks and months.
03
Apply
Patient insight, therapeutic monitoring, clinical workflows, research and life-sciences intelligence.
Pilot evidence
Tested with patients in the real world.
pilot participants
longitudinal check-ins
tracked across 20+ active days
said the platform could help them feel better prepared for appointments
30-day incentivised research pilot. Organic post-study use is now being measured.
Pilot data informed the next product, clinical and regulatory development phase.
From moments to meaning
A moment is useful. A pattern is more useful.
Longitudinal data helps show what changed, what preceded it and what happened next.
TreatmentSymptomsFunctionContextOutcomes
For people
Understand how symptoms change over time. Bring clearer evidence into care.
For care teams
See more of the treatment-response history between visits. Support richer clinical conversations.
For research
Build more representative longitudinal real-world evidence.
Built around context
Movement tells
part of the story.
Mylenium is designed to connect these observations within the same person over time.
Hardware-agnostic by design.
MovementTreatmentFunctionContextOver time
The longer view
The longer the history,
the richer the picture.
As longitudinal datasets grow, Mylenium aims to support increasingly precise understanding of treatment response across neurological conditions.
Long-term research includes deep phenotyping and treatment-response modelling.
Responsible by design
Built for healthcare from the beginning.
Clinical input
Product development is informed by clinical and patient perspectives.
Evidence
Validation is being developed alongside product development.
Safety + governance
Data protection, cybersecurity, clinical safety and regulatory requirements shape the roadmap.
Representation
Recruitment and evidence generation are being designed with underrepresented populations in mind.
Team
The people building Mylenium
Founder & CEO
Pierrette Hebga Meinrad
Policy and innovation background, with lived experience of neurological care and a focus on building more representative evidence systems.
LinkedIn
Engineer
Nizar Bikti
Full-stack and machine-learning capability supporting product and technical development.
LinkedIn
Strategy & Growth Advisor
Gunjan Arora
Strategy, operations and growth experience across complex organisations and scaling environments.
LinkedInInterested in what we are building?
We are speaking with investors, clinicians, researchers, patient organisations and potential partners.
Pre-seed round opening October 2026